{
  "id": 1754,
  "text": "As shown by Bloss et al.1640, the addition of bleomycin in the cisplatin/ifosfamide doublet did not improve outcome in terms of response rates, PFS and OS in patients with histologically confirmed, advanced (FIGO stage IVB), recurrent, or persistent squamous cell carcinoma of the cervix not suitable for curative treatment with surgery and/or radiotherapy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: As shown by Bloss et al.1640, the addition of bleomycin in the cisplatin/ifosfamide doublet did not improve outcome in terms of response rates, PFS and OS in patients with histologically confirmed, advanced (FIGO stage IVB), recurrent, or persistent squamous cell carcinoma of the cervix not suitable for curative treatment with surgery and/or radiotherapy.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究结果，添加博来霉素到顺铂和异环磷酰胺的联合治疗中，并没有提高对于FIGO IVB期复发性宫颈鳞状细胞癌患者的反应率、无进展生存期（PFS）和总生存期（OS）。因此，在这种情况下，博来霉素的加入并未显示出额外的治疗益处。",
  "query": "在治疗FIGO IVB期的复发性宫颈鳞状细胞癌时，加入博来霉素是否能提升使用顺铂和异环磷酰胺治疗的反应率、无进展生存期和总生存期？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗FIGO IVB期的复发性宫颈鳞状细胞癌时，加入博来霉素是否能提升使用顺铂和异环磷酰胺治疗的反应率、无进展生存期和总生存期？\n\n<reference text>: As shown by Bloss et al.1640, the addition of bleomycin in the cisplatin/ifosfamide doublet did not improve outcome in terms of response rates, PFS and OS in patients with histologically confirmed, advanced (FIGO stage IVB), recurrent, or persistent squamous cell carcinoma of the cervix not suitable for curative treatment with surgery and/or radiotherapy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究结果，添加博来霉素到顺铂和异环磷酰胺的联合治疗中，并没有提高对于FIGO IVB期复发性宫颈鳞状细胞癌患者的反应率、无进展生存期（PFS）和总生存期（OS）。因此，在这种情况下，博来霉素的加入并未显示出额外的治疗益处。"
}